4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-017106
CHAIRMAN AND CEO acquired 259,302 shares (grant or award)
- CHAIRMAN AND CEO acquired 93,976,905 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Trieu Vuong · CHAIRMAN AND CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-31 | Conversion : show line 1 in the form | +74,455,719 | 90,268,021 | D |
| 2021-07-08 | Grant or award : show line 2 in the form | +259,302 | 90,527,323 | D |
| 2021-03-31 | Conversion : show line 3 in the form | +13,849,161 | 16,780,384 | I |
| 2021-03-31 | Conversion : show line 4 in the form | +5,672,025 | 6,872,529 | I |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-31 | Conversion : show line 5 in the form Series A Convertible Preferred Stock | −74,456 | 0 | D |
| 2021-03-31 | Conversion : show line 6 in the form Series A Convertible Preferred Stock | −13,849 | 0 | I |
| 2021-03-31 | Conversion : show line 7 in the form Series A Convertible Preferred Stock | −5,672 | 0 | I |
| 2021-07-08 | Grant or award : show line 8 in the form Stock Options | +513,953 | 513,953 | D |
Loading xslF345X03/ownership.xml…